Insider · CIK 0001702969
Jay S Stout
officer
Files at IMVT (Immunovant, Inc.). First filing Oct 25, 2024, latest Oct 9, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 7
$0 bought, $425k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IMVT: Immunovant, Inc.
IMVTOct 9, 2026 · close 30.47
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | Immunovant, Inc. | $122k 3,809 shares | -2% | +99% from low-29% from high | |
| 30Weak | Immunovant, Inc. | $51k 2,805 shares | -1% | +38% from low-41% from high | |
| 28Weak | Immunovant, Inc. | $26k 1,519 shares | -1% | +30% from low-45% from high | |
| 35Weak | Immunovant, Inc. | $28k 1,925 shares | -1% | +9% from low-54% from high | |
| 38Weak | Immunovant, Inc. | $65k 5,004 shares | -2% | +12% from low-53% from high | |
| 37Weak | Immunovant, Inc. | $52k 2,195 shares | -2% | - | |
| 39Weak | Immunovant, Inc. | $81k 2,740 shares | -2% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 7, 2026 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -2,213 | $32.06 | $71k | 203,128 | 3 d ago |
| Oct 7, 2026 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -1,596 | $32.06 | $51k | 201,532 | 3 d ago |
| Jul 23, 2025 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -2,805 | $18.15 | $51k | 204,919 | Jul 25, 2025 |
| Jul 9, 2025 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -1,519 | $17.24 | $26k | 207,724 | Jul 11, 2025 |
| Apr 23, 2025 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -1,925 | $14.79 | $28k | 209,243 | Apr 25, 2025 |
| Apr 9, 2025 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -5,004 | $12.99 | $65k | 211,168 | Apr 11, 2025 |
| Apr 1, 2025 | IMVT Immunovant, Inc. | AGrant or award Common Stock | +76,181 | $0.00 | $0 | 216,172 | Apr 3, 2025 |
| Apr 1, 2025 | IMVT Immunovant, Inc. | AGrant or award Stock Option (right to buy)derivative | +107,297 | $0.00 | $0 | 107,297 | Apr 3, 2025 |
| Jan 22, 2025 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -2,195 | $23.59 | $52k | 139,991 | Jan 24, 2025 |
| Oct 23, 2024 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -2,740 | $29.53 | $81k | 142,186 | Oct 25, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.